CARISSA HORTON: Open Payments
NPI 1861489007 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,507 in 63 payments from 18 companies in 2025. Trend: 2023 $2,138 · 2024 $1,386 · 2025 $1,507
Food & beverage: $1,507
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 9 | $265 |
| Inspire Medical Systems, Inc. | 10 | $231 |
| GENZYME CORPORATION | 11 | $228 |
| AstraZeneca Pharmaceuticals LP | 11 | $217 |
| Smith+Nephew, Inc. | 2 | $87 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Abbott Laboratories | 1 | $60 |
| Viatris Specialty LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| JAZZ PHARMACEUTICALS INC. | 1 | $38 |
Products named: Prolastin-C Liquid, DUPIXENT, INSPIRE, FASENRA, AIRSUPRA, HALO, FREESTYLE LIBRE 3, YUPELRI.
Industry payments across KS — which companies pay providers there.
